Defining overweight and obesity among Greek children living in Thessaloniki: International versus local reference

A Christoforidis1, M Dimitriadou, E Papadopolou

  • 11 Paediatric Department, Aristotle University of Thessaloniki, Hippokratio Hospital, Thessaloniki, Greece.

Hippokratia
|November 24, 2011
PubMed

Insights

International Body Mass Index (BMI) references, such as the International Obesity Task Force (IOTF) and Centers for Disease Control and Prevention (CDC) standards, identify more overweight and obese children than Greek national references. Early detection and intervention are crucial for child health.

Area of Science:

  • Pediatrics
  • Public Health
  • Anthropometry

Background:

  • Childhood obesity is a growing public health concern.
  • Body Mass Index (BMI) is a key indicator for assessing weight status in children.
  • Accurate reference standards are essential for identifying overweight and obesity in pediatric populations.

Purpose of the Study:

  • To compare the diagnostic accuracy of international BMI references (IOTF, CDC) against national Greek references for identifying overweight and obese children.
  • To evaluate the prevalence of overweight and obesity in Greek children using different BMI-for-age curves.

Main Methods:

  • A cross-sectional study involving 1557 Greek children (mean age 11.42 years).
  • Weight and height were measured to calculate BMI.
  • Overweight and obesity were classified using International Obesity Task Force (IOTF), Centers for Disease Control and Prevention (CDC), and Greek national BMI-for-age standards.

Main Results:

  • The IOTF standards identified a significantly higher prevalence of overweight (22.4%) compared to CDC (11.8%) and Greek (7.4%) references.
  • The CDC standards indicated a higher prevalence of obesity (13.9%) than IOTF (6.5%) and Greek (6.9%) references.
  • National Greek references underestimated the prevalence of both overweight and obesity.

Conclusions:

  • National Greek BMI references are insufficient for accurately detecting overweight and obesity in children.
  • International standards (IOTF and CDC) are recommended for earlier identification and intervention of pediatric overweight and obesity.
  • Adoption of international references can improve clinical practice for managing child weight issues.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Hypodermis01:02

Hypodermis

The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...